Ambulatory medical device with therapy data sharing via wireless wide area network

A glucose level control system configured to generate a dose output for administration of medicament to a subject and to share therapy data related to therapy provided to the subject with a networked computing environment, the glucose level control system comprising:

• a memory configured to store specific computer-executable instructions;
• a wide area network transceiver configured to communicate over a wireless wide area network;
• and
• a hardware processor in communication with the memory and configured to execute the specific computer-executable instructions to at least:
• obtain an address of a computing system of a networked computing environment from a server configured to identify a recipient of therapy data;
• establish a direct end-to-end data connection to the computing system of the networked computing environment via the wireless wide area network using the address;
• receive a public key from the computing system of the networked computing environment, wherein the public key permits the glucose level control system to encrypt data communications transmitted by the glucose level control system to the computing system;
• encrypt therapy data related to therapy delivered by the glucose level control system to a subject to obtain encrypted therapy data;
• and
• transmit the encrypted therapy data to the computing system over the direct end-to-end data connection.

An glucose level control system configured to administer medicament to a subject in response to receiving a dose control signal and to share therapy data related to the therapy with a networked computing environment, the glucose level control system comprising:

• a memory configured to store specific computer-executable instructions;
• a wide area network transceiver configured to communicate over a wireless wide area network;
• and
• a hardware processor in communication with the memory and configured to execute the specific computer-executable instructions to at least:
• store in the memory therapy data related to the therapy;
• identify a computing system of a networked computing environment based on a whitelist of one or more approved computing systems, wherein the whitelist is stored in a memory of a trusted computing device;
• obtain an address of the computing system from the whitelist;
• establish a direct end-to-end data connection to the computing system of the networked computing environment via the wireless wide area network using the address;
• encrypt the therapy data related to therapy delivered by the glucose level control system to a subject to obtain encrypted therapy data;
• transmit the encrypted therapy data to the computing system over the direct end-to-end data connection;
• and
• transmit backup data to the computing system over the direct end-to-end data connection.

A computer-implemented method of sharing, with a networked computing environment, therapy data related to therapy provided by a glucose level control system to a subject, the computer-implemented method comprising:

• by a hardware processor of the glucose level control system,
• storing in a memory of the glucose level control system therapy data related to the therapy delivered by the glucose level control system to a subject;
• obtaining a unique identifier of a computing system of the networked computing environment based on a whitelist of one or more approved computing systems;
• establishing, using the unique identifier, a direct end-to-end data connection to the computing system of the networked computing environment via a wide area network, wherein the hardware processor establishes the direct end-to-end data connection via the wide area network using a wide area network transceiver of the glucose level control system;
• encrypting the therapy data to obtain encrypted therapy data, wherein the therapy corresponds to administering of medicament to the subject by the glucose level control system, wherein the glucose level control system is configured to administer the medicament to the subject in response to receiving a dose control signal;
• and
• transmitting the encrypted therapy data to the computing system over the direct end-to-end data connection.